Great West Life Assurance CO Collegium Pharmaceutical, Inc Transaction History

Great West Life Assurance CO

$69.9 Billion
Q3 2025

A detailed history of Great West Life Assurance CO transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Great West Life Assurance CO holds 39,933 shares of COLL stock, worth $1.84 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

39,933

Previous 39,933 -0.0%

Holding current value

$1.84 Million

Previous $1.18 Million 16.85%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$24.67 - $30.44 $45,343 - $55,948	-1,838 Reduced 4.4%	39,933 $1.18 Million
Q1 2025 May 15, 2025	SELL	$28.04 - $33.91 $103,579 - $125,263	-3,694 Reduced 8.12%	41,771 $1.25 Million
Q2 2024 Aug 12, 2024	BUY	$31.36 - $39.99 $426,903 - $544,383	13,613 Added 42.74%	45,465 $1.46 Million
Q1 2024 May 13, 2024	BUY	$31.23 - $40.91 $148,092 - $193,995	4,742 Added 17.49%	31,852 $1.24 Million
Q4 2023 Feb 13, 2024	SELL	$21.16 - $30.8 $112,021 - $163,055	-5,294 Reduced 16.34%	27,110 $835,000

Q3 2023 Nov 14, 2023	BUY	$21.23 - $24.28 $32,057 - $36,662	1,510 Added 4.89%	32,404 $724,000
Q2 2023 Aug 10, 2023	SELL	$21.06 - $24.0 $1,937 - $2,208	-92 Reduced 0.3%	30,894 $664,000
Q1 2023 May 12, 2023	SELL	$23.0 - $29.88 $281,497 - $365,701	-12,239 Reduced 28.31%	30,986 $743,000
Q4 2022 Feb 10, 2023	SELL	$16.14 - $23.55 $7,069 - $10,314	-438 Reduced 1.0%	43,225 $1 Million
Q3 2022 Nov 01, 2022	BUY	$15.46 - $20.1 $675,029 - $877,626	43,663 New	43,663 $699,000
Q2 2022 Aug 09, 2022	BUY	$14.22 - $20.88 $64,160 - $94,210	4,512 Added 15.63%	33,385 $592,000
Q1 2022 May 12, 2022	SELL	$17.2 - $22.5 $18,214 - $23,827	-1,059 Reduced 3.54%	28,873 $602,000
Q1 2021 May 17, 2021	BUY	$19.25 - $26.1 $532,416 - $721,873	27,658 Added 1216.27%	29,932 $708,000
Q3 2020 Nov 17, 2020	SELL	$15.78 - $20.82 $21,145 - $27,898	-1,340 Reduced 37.08%	2,274 $47,000
Q3 2020 Nov 13, 2020	BUY	$15.78 - $20.82 $21,145 - $27,898	1,340 Added 58.93%	3,614 $75,000
Q4 2019 Feb 11, 2020	BUY	$10.7 - $22.24 $24,331 - $50,573	2,274 New	2,274 $46,000
Q3 2019 Oct 25, 2019	SELL	$10.16 - $13.28 $43,545 - $56,918	-4,286 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$13.58 - $18.72 $39,191 - $54,025	2,886 Added 206.14%	4,286 $65,000
Q3 2017 Nov 09, 2017	BUY	$9.15 - $11.97 $12,810 - $16,758	1,400	1,400 $15,000

Others Institutions Holding COLL

# of Institutions

265

Shares Held

38M

Call Options Held

53.7K

Put Options Held

200

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.57B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account

Great West Life Assurance CO Collegium Pharmaceutical, Inc Transaction History